INS-1: Phase II

In a double-blind, placebo-controlled Phase II study of 61 patients, INSM said

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE